+91-9666438880
indiaord@gmail.com
IORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare Diseases
  • Home
  • About Us
    • Management Committee
    • Advisory Board
    • Newsletters
    • Newsletter Subscription
  • Rare Diseases
  • Research
  • Services
  • Donate
  • Gallery
    • Photo Gallery
      • World Rare Disease Day – 2023
      • World Rare Disease Day 2020
    • Video Gallery
      • World Rare Disease Day – 2020
      • World Rare Disease Day – 2019
      • World Rare Disease Day – 2018
  • Blog
  • Contact Us

OGH Makes History with Rare Liver Transplant

    Home Rare Disease News OGH Makes History with Rare Liver Transplant
    NextPrevious
    Osmania General Hospital Performs World's First Liver Transplant for Rare Marfan-Linked Hepatopulmonary Syndrome

    OGH Makes History with Rare Liver Transplant

    By IORD | Rare Disease News | 0 comment | 19 April, 2025 | 0

    Telangana Chief Minister A. Revanth Reddy praised Osmania General Hospital for successfully saving a youth’s life through a complex surgery.

    In a historic medical achievement, doctors at Osmania General Hospital (OGH), Hyderabad, successfully performed a living donor liver transplant on a 14-year-old boy suffering from rare Marfan Syndrome compounded by very severe Hepatopulmonary Syndrome (HPS) — marking the first such case in the world.

    The patient, G. Nikhil Reddy from Gokavaram, Machilipatnam in Andhra Pradesh, was born with Marfan Syndrome, a genetic disorder affecting connective tissue. Over the years, he developed complications including congenital glaucoma, cataract, and eventually chronic liver disease. Diagnosed at age 12 with HPS—a rare and serious liver-related condition that impairs oxygen exchange—his oxygen saturation had dropped to a critical 68%.

    Despite initial consultations at CMC Vellore, the case was referred to OGH due to its complexity. A multidisciplinary team at OGH, comprising departments of surgical gastroenterology, cardiology, pulmonology, anaesthesiology, radiology, and critical care, evaluated the patient thoroughly. The transplant surgery, led by Prof. Dr. CH Madhusudhan (HOD, Surgical Gastroenterology) and his team, was successfully performed on March 7, 2025, with Nikhil’s mother, G. Swathi, donating a portion of her liver.

    Post-surgery, the boy was managed in ICU for over a month. He is now stable, breathing without external oxygen support, and has an oxygen saturation level of 90%. This remarkable recovery has not only brought new hope to his family—daily wage laborers—but also set a new precedent in global transplant medicine.

    The team included Dr. Wasif Ali, Dr. Sudarshan Reddy, Dr. Abhimanyu Singh (HOD Anaesthesia), Prof. Chandra Shakar, and numerous experts across departments. Their coordinated effort, supported by the governments of Telangana and Andhra Pradesh through the Chief Minister’s Relief Fund (CMRF), made the Rs. 60-lakh equivalent procedure possible at no cost to the family.

    This case reinforces the life-saving potential of multidisciplinary collaboration in public healthcare, especially for rare and complex conditions. It also demonstrates how government hospitals can deliver world-class care, shattering stereotypes about public health institutions in India.

    What is Marfan Syndrome?

    Marfan Syndrome is a rare genetic disorder that affects approximately 1 in every 10,000 individuals worldwide. It is caused by mutations in the FBN1 gene, which encodes fibrillin-1, a key protein in connective tissue. What makes it rare and complex is its broad multi-organ involvement—from skeletal and ocular abnormalities to potentially life-threatening cardiovascular complications like aortic aneurysms.

    Complex pediatric liver transplant India, Government hospital medical achievement, Hepatopulmonary syndrome treatment, Liver transplant for Marfan syndrome, Osmania General Hospital surgery success, Prof. Dr. CH Madhusudhan, World's first HPS liver transplant

    IORD

    More posts by IORD

    Related Post

    • Inaugural session of World Rare Disease Day 2026 conference in Hyderabad, with experts from IORD, LVPEI, and Rainbow Children’s Hospital

      India: Rare Ophthalmic Disorders Take Centrestage at World Rare Disease Day-2026

      By IORD | 0 comment

      The event, attended by leading ophthalmologists, ocular geneticists, pediatric specialists, researchers, and patient advocates, spotlighted the urgent need for early diagnosis, stronger referral pathways, and expanded genetic and multidisciplinary services to address the growing burdenRead more

    • On World Rare Disease Day 2026, IORD, along with LV Prasad Eye Institute and Rainbow Children’s Hospital, is hosting a scientific conference in Hyderabad focused on Rare Ophthalmic Disorders

      IORD to Host World Rare Disease Day 2026 Conference Focused on Rare Ophthalmic Conditions

      By IORD | 0 comment

      Registration is now open. Limited seats available — register now using this link. Hyderabad, February 2026: The Indian Organisation for Rare Diseases (IORD), in collaboration with L V Prasad Eye Institute (LVPEI) and Rainbow Children’s Hospital,Read more

    • In this letter, IORD urges the Government of India to ensure affordable access to orphan drugs for rare disease patients through a public-interest, Section 8 non-profit pharmaceutical model supported by CSR funding.

      Bridging India’s Rare Disease Treatment Gap Through Public-Interest Pharmaceuticals

      By IORD | 0 comment

      IORD proposes a Section 8, CSR-supported public-interest pharmaceutical model to ensure affordable access to orphan drugs for millions of Indian patients.

    • IORD leaders urge inclusive, global collaboration to turn the WHA Rare Disease Resolution into real action at the RDI Asia-Pacific Webinar on October 9.

      From Hope to Action: IORD Calls for Inclusive Global Action on Rare Diseases

      By IORD | 0 comment

      The RDI Regional Webinar on “From the WHA Resolution to Action: Next Steps for Asia Pacific” marked a pivotal moment for regional cooperation on rare diseases.   “Hope” — that was the word chosen byRead more

    • Delhi High Court clears Natco to launch Risdiplam generic version Natsmart, making SMA treatment affordable for thousands of Indian families.

      Natco Wins Patent Battle, Makes SMA Drug Affordable in India

      By IORD | 0 comment

      Delhi High Court clears Natco to launch Risdiplam generic version Natsmart, making SMA treatment affordable for thousands.

    NextPrevious

    Categories

    • ABN Andhra Jyothi
    • ANI
    • Deccan Chronicle
    • Economic Times
    • Eenadu
    • Events
    • IORD in News
    • IORD Updates
    • News
    • Pharmabiz.com
    • Prime9 News
    • Rare Disease News
    • Rare Disease Survivor
    • Sakshi
    • Telangana Today
    • The Hans India
    • The Hindu
    • The Pioneer
    • Times Now
    • Times of India
    • Uncategorised
    • Vaartha

    Recent Posts

    • India: Rare Ophthalmic Disorders Take Centrestage at World Rare Disease Day-2026
    • IORD to Host World Rare Disease Day 2026 Conference Focused on Rare Ophthalmic Conditions
    • Bridging India’s Rare Disease Treatment Gap Through Public-Interest Pharmaceuticals
    • India Steps Forward as a Global Leader in Rare Disease Management
    • From Hope to Action: IORD Calls for Inclusive Global Action on Rare Diseases

    Archives

    • March 2026
    • February 2026
    • January 2026
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • March 2024
    • February 2024
    • December 2023
    • October 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • May 2021
    • April 2021
    • November 2020
    • March 2020
    • February 2020
    • January 2020
    • February 2019
    • January 2018
    • September 2015

    IORD

    Indian Organization For Rare Diseases (IORD), a not-for-profit umbrella organization represents interests of all stakeholders of Rare Diseases in India including individual patients, patient support groups, health policy advocates and health care providers.

    RARE DISEASES

    • Rare Blood Diseases
    • Rare Heart Diseases
    • Rare Fungal Diseases
    • Rare Kidney Diseases
    • Rare Newborn Diseases
    • more...

    SERVICES

    • Research
    • Let's Come Together
    • Partner With Us
    • Volunteers
    • Privacy Policy
    • Sitemap

    CONTACT US

    Indian Organization For Rare Diseases
    Registered Office (India):
    Plot No. 397, Road No. 22B, Jubilee Hills, Hyderabad – 500033, Telangana, India.

    Phone: +91-9666438880

    Email: indiaord@gmail.com

    © 2020 Indian Organization For Rare Diseases | All Rights Reserved. Powered By Digital Dynamics
    • Home
    • About Us
      • Management Committee
      • Advisory Board
      • Newsletters
      • Newsletter Subscription
    • Rare Diseases
    • Research
    • Services
    • Donate
    • Gallery
      • Photo Gallery
        • World Rare Disease Day – 2023
        • World Rare Disease Day 2020
      • Video Gallery
        • World Rare Disease Day – 2020
        • World Rare Disease Day – 2019
        • World Rare Disease Day – 2018
    • Blog
    • Contact Us
    IORD – Indian Organization for Rare Diseases